Completed PHASE3 INTERVENTIONAL 1-arm NCT03429400

Study of Oral Morphine Sulfate Administration in Pediatric Subjects

A Multicenter, Open-Label, Safety and Pharmacokinetic Study of Oral Morphine Sulfate Administration in Pediatric Subjects 2 Years Old Through 17 Years Old With Postoperative Pain

Sponsor: Premier Research

Conditions Pain, Postoperative

Interventions Morphine Sulfate

Updated 10 times since 2018 Last updated: Sep 24, 2019 Started: Apr 17, 2018 Primary completion: May 29, 2019 Completion: May 29, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Pain, Postoperative, this trial is completed. The trial is conducted by Premier Research and has accumulated 10 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

10 versions recorded

Nov 2025 — Present [monthly]

Completed PHASE3
Sep 2024 — Nov 2025 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Nov 2022 — Jul 2024 [monthly]

Completed PHASE3
Jan 2021 — Nov 2022 [monthly]

Completed PHASE3

▶ Show 5 earlier versions

Oct 2019 — Jan 2021 [monthly]

Completed PHASE3

Status: Recruiting → Completed
Aug 2018 — Oct 2019 [monthly]

Recruiting PHASE3

Status: Not Yet Recruiting → Recruiting
Jul 2018 — Aug 2018 [monthly]

Not Yet Recruiting PHASE3
Jun 2018 — Jul 2018 [monthly]

Not Yet Recruiting PHASE3
Mar 2018 — Jun 2018 [monthly]

Not Yet Recruiting PHASE3

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Premier Research
West-Ward Pharmaceutical

Data source: West-Ward Pharmaceutical

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Sheffield, United States